NEW YORK (GenomeWeb News) – Fluidigm has raised $18.2 million through the private placement of an undisclosed number of shares, according to a filing with the US Securities and Exchange Commission.

The South San Francisco, Calif.-based firm is seeking to raise up to a total of $24.1 million from the offering, according to the SEC filing.

A Fluidigm spokesman confirmed the amount of money raised so far, but he could not provide any further details at this time.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers suggest that genetic variations could influence the side effects people experience when using synthetic cannabinoids, the International Business Times reports.

An analysis has examined the makeup of researchers on Twitter and what they share, Nature News reports.

At Stat News, Jim Kozubek argues that the Broad Institute is pushing the boundary of what a nonprofit is.

In PNAS this week: gut microbes may affect honeybee weight, phenotype and gene expression changes in DiGeorge syndrome, and more.